Novartis Aktie
110,40
EUR
-1,70
EUR
-1,52
%
102,14
CHF
-1,94
CHF
-1,86
%
Werbung
Novartis Aktie Analyse
| 13.04.15 | Novartis buy | Jefferies & Company Inc. | |
| 08.04.15 | Novartis buy | UBS AG | |
| 04.03.15 | Novartis Outperform | BNP PARIBAS | |
| 02.03.15 | Novartis buy | UBS AG | |
| 20.02.15 | Novartis buy | Jefferies & Company Inc. | |
| 09.02.15 | Novartis buy | Citigroup Corp. | |
| 28.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 23.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.15 | Novartis Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis buy | UBS AG | |
| 21.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.01.15 | Novartis buy | Kepler Cheuvreux | |
| 16.01.15 | Novartis buy | UBS AG | |
| 16.01.15 | Novartis buy | Jefferies & Company Inc. | |
| 16.01.15 | Novartis buy | S&P Capital IQ | |
| 05.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 12.12.14 | Novartis buy | UBS AG | |
| 28.11.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.11.14 | Novartis Outperform | BNP PARIBAS | |
| 13.11.14 | Novartis buy | UBS AG | |
| 10.11.14 | Novartis buy | Jefferies & Company Inc. | |
| 05.11.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.10.14 | Novartis buy | S&P Capital IQ | |
| 23.10.14 | Novartis buy | UBS AG | |
| 14.10.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 15.09.14 | Novartis buy | Jefferies & Company Inc. | |
| 11.09.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 04.09.14 | Novartis Outperform | BNP PARIBAS | |
| 02.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 01.09.14 | Novartis buy | UBS AG | |
| 22.08.14 | Novartis Outperform | Credit Suisse Group | |
| 21.08.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.08.14 | Novartis buy | UBS AG | |
| 21.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 17.07.14 | Novartis buy | S&P Capital IQ | |
| 14.07.14 | Novartis buy | UBS AG | |
| 14.07.14 | Novartis buy | Jefferies & Company Inc. | |
| 14.07.14 | Novartis buy | Jefferies & Company Inc. | |
| 07.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 02.07.14 | Novartis buy | UBS AG | |
| 19.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.06.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.06.14 | Novartis buy | UBS AG | |
| 18.06.14 | Novartis Outperform | Bernstein Research | |
| 03.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 27.05.14 | Novartis Outperform | BNP PARIBAS | |
| 27.05.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 16.05.14 | Novartis buy | Société Générale Group S.A. (SG) | |
Werbung
Werbung